Literature DB >> 22330073

The macrophage response towards LPS and its control through the p38(MAPK)-STAT3 axis.

Johannes G Bode1, Christian Ehlting, Dieter Häussinger.   

Abstract

In macrophages detection of gram-negative bacteria particularly involves binding of the outer-wall component lipopolysaccharide (LPS) to its cognate receptor complex, comprising Toll like receptor 4 (TLR4), CD14 and MD2. LPS-induced formation of the LPS receptor complex elicits a signaling network, including intra-cellular signal-transduction directly activated by the TLR4 receptor complex as well as successional induction of indirect autocrine and paracrine signaling events. All these different pathways are integrated into the macrophage response towards an inflammatory stimulus by a highly complex cross-talk of the pathways engaged. This also includes a tight control by several intra- and inter-cellular feedback loops warranting an inflammatory response sufficient to battle invading pathogens and to avoid non-essential tissue damage caused by an overwhelming inflammatory response. Several evidences indicate that the reciprocal cross-talk between the p38(MAPK)-pathway and signal transducer and activator of transcription (STAT)3-mediated signal-transduction forms a critical axis successively activated by LPS. The balanced activation of this axis is essential for both induction and propagation of the inflammatory macrophage response as well as for the control of the resolution phase, which is largely driven by IL-10 and sustained STAT3 activation. In this context regulation of suppressor of cytokine signaling (SOCS)3 expression and the recently described divergent regulatory roles of the two p38(MAPK)-activated protein kinases MK2 and MK3 for the regulation of LPS-induced NF-κB- and IRF3-mediated signal-transduction and gene expression, which includes the regulation of IFNβ, IL-10 and DUSP1, appears to play an important role.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22330073     DOI: 10.1016/j.cellsig.2012.01.018

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  142 in total

1.  Stevioside suppressed inflammatory cytokine secretion by downregulation of NF-κB and MAPK signaling pathways in LPS-stimulated RAW264.7 cells.

Authors:  Li Fengyang; Fu Yunhe; Liu Bo; Liu Zhicheng; Li Depeng; Liang Dejie; Zhang Wen; Cao Yongguo; Zhang Naisheng; Zhang Xichen; Yang Zhengtao
Journal:  Inflammation       Date:  2012-10       Impact factor: 4.092

2.  Soluble CD83 Inhibits T Cell Activation by Binding to the TLR4/MD-2 Complex on CD14+ Monocytes.

Authors:  Joe M Horvatinovich; Elizabeth W Grogan; Marcus Norris; Alexander Steinkasserer; Henrique Lemos; Andrew L Mellor; Irina Y Tcherepanova; Charles A Nicolette; Mark A DeBenedette
Journal:  J Immunol       Date:  2017-02-13       Impact factor: 5.422

3.  Genomic and lipidomic analyses differentiate the compensatory roles of two COX isoforms during systemic inflammation in mice.

Authors:  Xinzhi Li; Liudmila L Mazaleuskaya; Laurel L Ballantyne; Hu Meng; Garret A FitzGerald; Colin D Funk
Journal:  J Lipid Res       Date:  2017-11-27       Impact factor: 5.922

4.  The activating effect of IFN-γ on monocytes/macrophages is regulated by the LIF-trophoblast-IL-10 axis via Stat1 inhibition and Stat3 activation.

Authors:  Angham Dallagi; Julie Girouard; Jovane Hamelin-Morrissette; Rachel Dadzie; Laetitia Laurent; Cathy Vaillancourt; Julie Lafond; Christian Carrier; Carlos Reyes-Moreno
Journal:  Cell Mol Immunol       Date:  2014-07-14       Impact factor: 11.530

Review 5.  Small Heat Shock Proteins, Amyloid Fibrils, and Nicotine Stimulate a Common Immune Suppressive Pathway with Implications for Future Therapies.

Authors:  Jonathan B Rothbard; Michael P Kurnellas; Shalina S Ousman; Sara Brownell; Jesse J Rothbard; Lawrence Steinman
Journal:  Cold Spring Harb Perspect Med       Date:  2019-07-01       Impact factor: 6.915

6.  Innate PI3K p110δ regulates Th1/Th17 development and microbiota-dependent colitis.

Authors:  Erin C Steinbach; Taku Kobayashi; Steven M Russo; Shehzad Z Sheikh; Gregory R Gipson; Samantha T Kennedy; Jennifer K Uno; Yoshiyuki Mishima; Luke B Borst; Bo Liu; Hans Herfarth; Jenny P Y Ting; R Balfour Sartor; Scott E Plevy
Journal:  J Immunol       Date:  2014-03-14       Impact factor: 5.422

7.  Dexmedetomidine alleviates LPS-induced septic cardiomyopathy via the cholinergic anti-inflammatory pathway in mice.

Authors:  Weilan Kong; Kai Kang; Yang Gao; Haitao Liu; Xianglin Meng; Songliu Yang; Kaijiang Yu; Mingyan Zhao
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

8.  Infliximab therapy increases the frequency of circulating CD16(+) monocytes and modifies macrophage cytokine response to bacterial infection.

Authors:  N Nazareth; F Magro; J Silva; M Duro; D Gracio; R Coelho; R Appelberg; G Macedo; A Sarmento
Journal:  Clin Exp Immunol       Date:  2014-09       Impact factor: 4.330

9.  2,8-Decadiene-1,10-Diol Inhibits Lipopolysaccharide-Induced Inflammatory Responses Through Inactivation of Mitogen-Activated Protein Kinase and Nuclear Factor-κB Signaling Pathway.

Authors:  Mi-Sun Kim; Eun-Kyung Ahn; Seong Su Hong; Joa Sub Oh
Journal:  Inflammation       Date:  2016-04       Impact factor: 4.092

10.  TLR4 mediates MAPK-STAT3 axis activation in bladder epithelial cells.

Authors:  Huang Ying; Liu Da; Shi Yu-xiu; Xia Yu; Liu Li-xia; Xie Li-mei; Ren Wei-dong
Journal:  Inflammation       Date:  2013-10       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.